GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by TD Private Client Wealth LLC

TD Private Client Wealth LLC lowered its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 7.2% in the fourth quarter, HoldingsChannel reports. The firm owned 10,648 shares of the company’s stock after selling 830 shares during the period. TD Private Client Wealth LLC’s holdings in GE HealthCare Technologies were worth $832,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in GEHC. Lee Danner & Bass Inc. acquired a new position in GE HealthCare Technologies in the fourth quarter worth $80,000. Whittier Trust Co. of Nevada Inc. lifted its stake in GE HealthCare Technologies by 4.4% in the fourth quarter. Whittier Trust Co. of Nevada Inc. now owns 77,355 shares of the company’s stock valued at $6,047,000 after buying an additional 3,240 shares during the last quarter. Whittier Trust Co. boosted its holdings in shares of GE HealthCare Technologies by 4.4% during the fourth quarter. Whittier Trust Co. now owns 126,897 shares of the company’s stock valued at $9,921,000 after acquiring an additional 5,328 shares during the period. iA Global Asset Management Inc. grew its position in shares of GE HealthCare Technologies by 38.6% during the fourth quarter. iA Global Asset Management Inc. now owns 64,538 shares of the company’s stock worth $5,046,000 after acquiring an additional 17,987 shares during the last quarter. Finally, Teacher Retirement System of Texas increased its holdings in shares of GE HealthCare Technologies by 167.8% in the 4th quarter. Teacher Retirement System of Texas now owns 112,203 shares of the company’s stock worth $8,772,000 after acquiring an additional 70,300 shares during the period. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $81.49 on Monday. The firm has a 50-day moving average of $87.02 and a two-hundred day moving average of $86.02. The company has a market capitalization of $37.27 billion, a price-to-earnings ratio of 18.82, a PEG ratio of 3.19 and a beta of 1.13. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. GE HealthCare Technologies Inc. has a twelve month low of $74.51 and a twelve month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating the consensus estimate of $1.26 by $0.19. The business had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. As a group, analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have commented on the stock. Citigroup upped their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, February 13th. Wells Fargo & Company lifted their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, February 14th. The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and increased their price target for the stock from $85.00 to $100.00 in a research note on Tuesday, March 11th. Finally, Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price target for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $98.75.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.